ClinicalTrials.Veeva

Menu

Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.

S

Shandong University

Status

Unknown

Conditions

Duodenum
Mucosal Microbiome
Gastric Intestinal Metaplasia

Treatments

Other: endomicroscopy, targeted biopsy and 16s rRNA gene sequencing

Study type

Observational

Funder types

Other

Identifiers

NCT02428426
2015SDU-QILU-G04

Details and patient eligibility

About

To investigate the mucosal microbiome in human gastric intestinal etaplasia and duodenal tissue.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients scheduled for gastroendoscopy examination Aged between 18 and 80 years old

Exclusion criteria

  • Antibiotic, probiotic or prebiotic usage within 2months,gastric inhibitor usage within 1 month Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium Pregnant or breast-feeding (for females) Impaired renal function

Trial design

20 participants in 2 patient groups

gastric intestinal metaplasia
Description:
patients were diagnosed gastric intestinal metaplasia
Treatment:
Other: endomicroscopy, targeted biopsy and 16s rRNA gene sequencing
gastritis
Description:
patients were diagnosed non atrophic gastritis
Treatment:
Other: endomicroscopy, targeted biopsy and 16s rRNA gene sequencing

Trial contacts and locations

1

Loading...

Central trial contact

li yanqing, PhD,MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems